Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frovatriptan for prevention of menstrually related migraine in a difficult-to-treat population
2004-001969-17Phase 3Completed
- Sponsor
- Vernalis
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of frovatriptan in migraine (3 arms), sponsored by Vernalis. Primary endpoint: Number of MRM headache-free peri-menstrual periods. Started Oct 2004; status: completed.
02
Drugs
frovatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on 2004-001969-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001969-17.